Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 2-tert-butyl-4-((2-((tert-butyldimethylsilyloxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylamino)methyl)thiazole-5-carboxylate is a complex organic compound with a diverse array of functional groups, including methyl, tert-butyl, dimethylsilyloxy, and thiazole-5-carboxylate. It also features a dioxaborolan-2-yl moiety and a phenylamino group. This intricate structure suggests potential applications in research or as a precursor in the synthesis of other organic molecules.

1361941-37-8

Post Buying Request

1361941-37-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1361941-37-8 Usage

Uses

Used in Research Applications:
Methyl 2-tert-butyl-4-((2-((tert-butyldimethylsilyloxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylamino)methyl)thiazole-5-carboxylate is used as a research compound for exploring its chemical properties and potential interactions with other molecules.
Used in Organic Synthesis:
In the field of organic synthesis, methyl 2-tert-butyl-4-((2-((tert-butyldimethylsilyloxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylamino)methyl)thiazole-5-carboxylate is used as a precursor for the synthesis of other complex organic molecules, leveraging its various functional groups to facilitate chemical reactions and the formation of desired products.

Check Digit Verification of cas no

The CAS Registry Mumber 1361941-37-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,1,9,4 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1361941-37:
(9*1)+(8*3)+(7*6)+(6*1)+(5*9)+(4*4)+(3*1)+(2*3)+(1*7)=158
158 % 10 = 8
So 1361941-37-8 is a valid CAS Registry Number.

1361941-37-8Relevant academic research and scientific papers

PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF

-

Page/Page column 116-117, (2012/03/26)

Pyridone and pyrazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1361941-37-8